![Chase LoPriore](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 82 500 $ as of 31/05/2026
Chase LoPriore began a role as Director at Hepion Pharmaceuticals, Inc. in 2026 and continues in this position.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 28/04/2026 | 1,250,000 ( 4.29% ) | 82 500 $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| HEPION PHARMACEUTICALS, INC. | Director/Board Member | 12/03/2026 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 1 |
|---|---|
Hepion Pharmaceuticals, Inc.
 Hepion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug therapy for treatment of chronic liver diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
